These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 15995307

  • 1. [Functional disorder of the parathyroid gland and vascular calcification in hemodialysis patients].
    Nakanishi S, Fukagawa M.
    Clin Calcium; 2005 Jul; 15(7):119-23. PubMed ID: 15995307
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.
    Caudrillier A, Mentaverri R, Brazier M, Kamel S, Massy ZA.
    J Nephrol; 2010 Nov; 23(1):17-22. PubMed ID: 20091482
    [Abstract] [Full Text] [Related]

  • 4. Effects of dialysis prescription on bone and mineral metabolism: the National Cooperative Dialysis Study.
    Harter HR, Laird NM, Teehan BP.
    Kidney Int Suppl; 1983 Apr; (13):S73-9. PubMed ID: 6345900
    [No Abstract] [Full Text] [Related]

  • 5. [Experimental study of the mechanism for vascular calcification in chronic kidney disease].
    Persy V.
    Verh K Acad Geneeskd Belg; 2008 Apr; 70(4):285-303. PubMed ID: 19166100
    [Abstract] [Full Text] [Related]

  • 6. Management of calcium, phosphorus and bone metabolism in dialysis patients using sevelamer hydrochloride and vitamin D therapy.
    Ishida M, Yao N, Yachiku S, Anzai T, Kobayashi T, Ishida H.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S16-21. PubMed ID: 16109136
    [Abstract] [Full Text] [Related]

  • 7. Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report.
    Eisenberg B, Tzamaloukas AH, Hartshorne MF, Listrom MB, Arrington ER, Sherrard DJ.
    J Nucl Med; 1990 Jun; 31(6):1099-103. PubMed ID: 2348239
    [Abstract] [Full Text] [Related]

  • 8. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R.
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [Abstract] [Full Text] [Related]

  • 9. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A, Nishizawa Y.
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [Abstract] [Full Text] [Related]

  • 10. Clinical, histological, and chemical characterization of ectopic calcification in dialyzed and non-dialyzed patients.
    Portigliatti Barbos M, Cadario A, Canavese C, Pavan I.
    Ital J Orthop Traumatol; 1991 Dec; 17(4):523-32. PubMed ID: 1816158
    [Abstract] [Full Text] [Related]

  • 11. Vascular calcification and disordered mineral metabolism in dialysis patients.
    Kalpakian MA, Mehrotra R.
    Semin Dial; 2007 Dec; 20(2):139-43. PubMed ID: 17374088
    [Abstract] [Full Text] [Related]

  • 12. Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia.
    Drüeke TB, Massy ZA.
    Blood Purif; 2002 Dec; 20(5):494-7. PubMed ID: 12207101
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of factors promoting vascular calcinosis in long-term hemodialysis patients].
    Renaud H, Attik H, Hervé M, Benelmouffok S, Galy C, Kambia B, Morinière P, Fournier A.
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1696-700. PubMed ID: 3938242
    [Abstract] [Full Text] [Related]

  • 14. Vascular calcification: Hardening of the evidence.
    Moe SM.
    Kidney Int; 2006 Nov; 70(9):1535-7. PubMed ID: 17051256
    [Abstract] [Full Text] [Related]

  • 15. Soft-tissue calcification in uremia.
    Parfitt AM.
    Arch Intern Med; 1969 Nov; 124(5):544-56. PubMed ID: 4899444
    [No Abstract] [Full Text] [Related]

  • 16. Vascular calcification in uremic conditions: new insights into pathogenesis.
    Cozzolino M, Gallieni M, Brancaccio D.
    Semin Nephrol; 2006 Jan; 26(1):33-7. PubMed ID: 16412823
    [Abstract] [Full Text] [Related]

  • 17. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis.
    Raggi P, Giachelli C, Bellasi A.
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):26-33. PubMed ID: 17180147
    [Abstract] [Full Text] [Related]

  • 18. Cardiac and pulmonary calcification in a hemodialysis patient: partial regression 4 years after parathyroidectomy.
    Di Leo C, Gallieni M, Bestetti A, Tagliabue L, Cozzolino M, Carpani P, Pozzato C, Tarolo GL, Brancaccio D.
    Clin Nephrol; 2003 Jan; 59(1):59-63. PubMed ID: 12572933
    [Abstract] [Full Text] [Related]

  • 19. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H, Koiwa F, Shishido K, Takahashi K, Ito H, Kinugasa E, Taguchi S.
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
    Capuano A, Serio V, Pota A, Memoli B, Andreucci VE.
    J Nephrol; 2009 Jun; 22(1):59-68. PubMed ID: 19229819
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.